All 1 tracked stories fall under one category: talent. Ipsen Pharma is most often covered alongside Ipsen, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Ipsen Pharma
All 1 tracked stories fall under one category: talent. Ipsen Pharma is most often covered alongside Ipsen, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 1 HR & Workforce story that mention Ipsen Pharma, all published on March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 HR & Workforce stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Ipsen Pharma. Shared-story counts are live from our verified record — not editorial picks.
Ipsen has appointed Michelle C. Werner as Executive Vice President and President of North America to spearhead its growth in the region. Werner brings extensive biopharmaceutical leadership experience to the role as the company seeks to strengthen its specialty care portfolio.